Mayne Pharma Group Limited (ASX:MYX – Get Rating) insider Frank Condella purchased 3,210 shares of the company's stock in a transaction dated Monday, March 27th. The stock was purchased at an average price of A$3.52 ($2.34) per share, with a total value of A$11,289.57 ($7,526.38).

Frank Condella also recently made the following trade(s):

• On Friday, March 24th, Frank Condella bought 17,788 shares of Mayne Pharma Group stock. The stock was purchased at an average price of A$3.52 ($2.35) per share, with a total value of A$62,684.91 ($41,789.94).

Mayne Pharma Group Price Performance

The company has a debt-to-equity ratio of 10.18, a current ratio of 1.45 and a quick ratio of 0.62.

About Mayne Pharma Group

(Get Rating)

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products.

Read More

• The Bottom Is In For McCormick & Company
• Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
• Roku And The 20% Rally That's About To Start
• It's Rally-On! For PVH Corp. But How High Can It Go?
• Don't Be Fooled by These 3 Value Traps

Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.